DRUG · Mapped RxNorm record
Liraglutide
Normalized identity: liraglutideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
NCT01800968
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Placebo
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedFunctional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Acute Heart Failureunresolved
Interventions
LiraglutideDRUG · verified · RxNorm: liraglutide
PlaceboDRUG
Sponsors & collaborators
Duke Universitylead sponsor
Mapped research locations
BostonMassachusetts, United States3PhiladelphiaPennsylvania, United States3ClevelandOhio, United States3St LouisMissouri, United States2Salt Lake CityUtah, United States2HoustonTexas, United States1ChicagoIllinois, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1DurhamNorth Carolina, United States1RochesterMinnesota, United States1NewarkDelaware, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01800968 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.